Change in daily volume of beer sold (% (95% CI) with intervention. by Eleni Mantzari (6991172)

Subjects:

Heteroscedastic linear mixed model main results, estimating the volume (ml) of beer sold per day on the transformed (cube root) scale, on the original scale and on the relative sca... by Eleni Mantzari (6991172)

Subjects:

Characteristics of participating licensed premises. by Eleni Mantzari (6991172)

Subjects:

Flow of premises through the study. by Eleni Mantzari (6991172)

Subjects:

Unadjusted mean (SD) volume (ml) of beer sold per day, overall and by serving size, and volume of wine (ml) sold of premises included in primary analysis (<i>n</i> = 12). by Eleni Mantzari (6991172)

Subjects:

Forest plot and volcano plot of ROR values (95% CI) for the first 30 high signal intensity AEs of penicillamine versus trientine. by Wenlong Qian (22608053)

Subjects:

Provider costs for TB provision by clinical outcome (mean, calculated 95% CI) (USD 2022). by Denise Evans (288201)

Subjects:

Largest changes in influenza vaccine rates, Pre- vs. Post-COVID-19. by Tyler B. Nofzinger (21560244)

Subjects:

The global numbers of prevalent cases (A), incident cases (B), deaths (C), DALYs (D), and corresponding rates of chronic obstructive pulmonary disease per 100,000 population in old... by Kaifang Meng (13848535)

Subjects:

Prevalence and EAPC of chronic obstructive pulmonary disease among adults aged ≥70 years at the global and regional levels, from 1990 to 2021. by Kaifang Meng (13848535)

Subjects:

Trends of death rates due to chronic obstructive pulmonary disease attributable to each risk factor among adults aged ≥70 years in 5 sociodemographic index regions, from 1990–2021.... by Kaifang Meng (13848535)

Subjects:

Map showing prevalence (A), incidence (B), deaths (C), and DALYs (D) rates of chronic obstructive pulmonary disease per 100,000 population among adults aged ≥70 years in 2021, by c... by Kaifang Meng (13848535)

Subjects:

Trends of prevalence (A), incidence (B) deaths (C), and DALYs (D) rates of chronic obstructive pulmonary disease per 100,000 population among adults aged ≥70 years by sex and socio... by Kaifang Meng (13848535)

Subjects:

Map showing estimated annual percentage changes of prevalence (A), incidence (B), deaths (C), and DALYs (D) rates of chronic obstructive pulmonary disease among adults aged ≥70 yea... by Kaifang Meng (13848535)

Subjects:

The association between the sociodemographic index and the prevalence rates of chronic obstructive pulmonary disease per 100,000 population among adults aged ≥70 years across 21 re... by Kaifang Meng (13848535)

Subjects:

Alcohol-related monthly crude rates for ages 15 and older between 2018 and 2024, stratified by gender and race. by Tony Wong (779773)

Subjects:

Selection and screening of study participants. by Weixin Chen (138569)

Subjects:

The top 10 putative metabolites with the largest negative fold change between normal and thin cows. by Bhuripit Saraphol (20855573)

The top 10 putative metabolites with the largest positive fold change between normal and thin cows. by Bhuripit Saraphol (20855573)

Patient flowchart. by Anna D. Ware (19688153)

“…Preexisting aspirin prescription was associated with a significant decrease risk of post-COVID-19 thromboembolic disorders, including pulmonary embolism (OR [95% CI]: 0.69 [0.65, 0.74]) and deep vein thrombosis (OR [95% CI]: 0.76 [0.69, 0.83], but an increased risk of acute arterial diseases, including ischemic stroke (OR [95% CI]: 1.54 [1.46, 1.60]) and acute ischemic heart disease (1.33 [1.26, 1.39]).…”